Loading...
01/11 04:25
Loading...
Access earnings results, analyst expectations, report, slides, earnings call, and transcript.
The earnings call highlights a significant improvement in gross profit and a reduced net loss, indicating better financial performance. The increase in waste backlog and the anticipated start of the Hanford project provide strong growth prospects. Despite challenges in the Services segment and regulatory delays, the company's strategic initiatives, such as the PFAS program and Gen II deployment, are promising. The Q&A session reflects confidence in overcoming operational hurdles. Overall, the positive financial trajectory and growth initiatives suggest a positive stock price movement.
Revenue Total revenue for Q2 2025 was $14.6 million, an increase of $600,000 or 4.3% year-over-year. The increase was driven by a $3.1 million rise in the Treatment segment revenue (36.6% increase) due to higher waste volumes and average waste prices. However, this was offset by a $2.5 million decrease in the Services segment revenue due to project delays and the completion of large projects in the prior year.
Gross Profit Gross profit for Q2 2025 was $1.5 million, an improvement of $2.8 million compared to a negative $1.3 million in Q2 2024. The improvement was due to a $3.4 million positive impact from increased revenue and lower variable costs of waste treated, partially offset by $683,000 in increased fixed costs, primarily labor-related.
SG&A Costs SG&A costs for Q2 2025 were $4.1 million, up from $3.5 million in the prior year. The increase was evenly split between higher marketing expenses (due to business development for PFAS and project bidding) and higher administrative costs (due to the addition of a COO and related expenses).
Net Loss Net loss for Q2 2025 was $2.7 million, an improvement from a net loss of $4 million in Q2 2024. This equates to a loss per share of $0.15 compared to $0.27 in the prior year.
EBITDA EBITDA from continuing operations for Q2 2025 was negative $2.3 million, an improvement from negative $4.6 million in Q2 2024.
Cash on Balance Sheet Cash on the balance sheet at the end of Q2 2025 was $22.6 million.
Waste Backlog Waste backlog at the end of Q2 2025 was $13.2 million, up from $7.9 million at the end of 2024 and $8.7 million at the end of Q2 2024.
PFAS-related sales: Year-to-date PFAS-related sales reached approximately $500,000, representing about 30,000 gallons of material.
Gen 2 system development: Construction is underway on the Gen 2 system in Oak Ridge, Tennessee, designed to process up to 3,000 gallons of production per day while reducing unit operating costs. It also supports mobile field deployment options for landfills, waste treatment plants, and remote sites.
International waste receipts: Received over $7 million in waste receipts during the past 2 quarters, with strong interest from customers in Canada, Germany, Mexico, and Italy.
European Union contract: EUR 50 million contract in Italy is progressing through the permitting and preparation phase, with treatment operations expected to begin in 2026.
Treatment segment revenue growth: Revenue increased approximately 37% year-over-year, with waste receipts more than doubling to approximately $14 million in Q2 2025.
Operational improvements: Automation and process improvements enhanced throughput, improved safety, and reduced manual labor.
Cost management initiatives: Disciplined cost management and targeted margin improvement initiatives are contributing to improved productivity and expected stronger EBITDA performance in the second half of 2025.
Navy's RADMAC III IDIQ contract: Awarded a position on the $240 million contract, reinforcing competencies in radiological cleanup and providing potential task order opportunities.
West Valley project: Entered a 6-month planning period as part of the BWXT-led team, with expectations to play a key role in long-term DOE cleanup efforts.
Federal and commercial procurement opportunities: Pursuing bids with the U.S. Army Corps of Engineers and DOE National Laboratories, representing more than $200 million in potential contract value.
Technical challenges in Treatment segment: Technical challenges limited production capacity early in the quarter, impacting operational efficiency and revenue generation. Although resolved, these issues highlight potential risks in maintaining consistent production.
Delay in DFLAW facility start-up: The Department of Energy's delay in the DFLAW facility start-up from August 1 to as late as October 15 could impact short-term revenue streams and operational planning.
Project delays in Services segment: Delays in federal government and procurement timing earlier in the quarter affected project execution and revenue in the Services segment.
Increased fixed costs in Treatment segment: Higher fixed costs, primarily labor-related, due to increased waste receipts, could pressure margins if not offset by revenue growth.
Decreased revenue in Services segment: Revenue in the Services segment decreased by $2.5 million due to project delays and completion of large projects in the prior year, indicating potential volatility in this segment.
Regulatory and permitting challenges: The EUR 50 million contract in Italy is still in the permitting and preparation phase, which could delay revenue realization and operational execution.
Increased SG&A costs: Higher SG&A costs, driven by marketing expenses and administrative additions, could strain profitability if not matched by revenue growth.
Revenue Growth: The company expects to realize the full benefit of automation and process improvements in the second half of 2025, enhancing throughput, safety, and reducing manual labor. Additionally, the DFLAW program, despite a short-term delay, is anticipated to contribute substantial recurring revenue and cash flow once operational.
Services Segment: Field execution and cleanup work is now tracking on schedule across key DOE and DOD sites. The company expects to play a key role in the West Valley project, a significant multiyear opportunity for the services business, with revenue recognition tied to DOE's approval of the final performance strategy later this year.
PFAS Technology: Construction is underway on the Gen 2 system in Oak Ridge, Tennessee, designed to process up to 3,000 gallons per day while reducing operating costs. This system is expected to support mobile field deployment options and enhance scalability.
International Operations: The EUR 50 million contract with the European Union in Italy is progressing through the permitting and preparation phase, with treatment operations expected to begin in 2026.
Federal and Commercial Procurement Opportunities: The company is pursuing bids with the U.S. Army Corps of Engineers and DOE National Laboratories, representing more than $200 million in potential contract value, with award decisions expected in the first half of 2026.
Waste Backlog: The current waste backlog of approximately $13.2 million provides strong visibility into second-half treatment volumes and service activities.
Market Trends and Policy: Evolving PFAS policy and regulatory developments at federal and state levels are expected to support demand for the company's destructive technologies.
The selected topic was not discussed during the call.
The earnings call summary presents a mixed outlook. Financial performance and shareholder returns show improvement, but the guidance lacks clarity, especially regarding margins and partnerships. Q&A insights reveal uncertainties in PFAS progress and waste treatment margins, balanced by strong backlog and potential contracts. No clear catalyst for a strong price movement is evident, leading to a neutral sentiment.
The earnings call highlights a significant improvement in gross profit and a reduced net loss, indicating better financial performance. The increase in waste backlog and the anticipated start of the Hanford project provide strong growth prospects. Despite challenges in the Services segment and regulatory delays, the company's strategic initiatives, such as the PFAS program and Gen II deployment, are promising. The Q&A session reflects confidence in overcoming operational hurdles. Overall, the positive financial trajectory and growth initiatives suggest a positive stock price movement.
The earnings call presents a mixed picture: modest revenue growth and improved gross profit are overshadowed by consistent net losses and negative EBITDA. The Q&A reveals potential in waste receipts and PFAS technology, but management's vague responses on margins and project timelines raise concerns. The absence of a share repurchase program and international expansion risks further balance the outlook. Overall, the stock is likely to remain stable, with no strong catalysts for significant movement.
The earnings call highlighted modest revenue growth and improved profitability metrics, but persistent net losses and cash decline are concerns. The Q&A revealed increased waste receipts from Hanford, but management's vague responses on margins and budget impacts raise uncertainties. The absence of a shareholder return plan and international expansion risks further temper sentiment. Despite potential PFAS demand growth, competitive pressures and no new partnerships or guidance adjustments limit positive catalysts. Overall, the mixed financial performance and strategic outlook suggest a neutral stock price movement.
All transcripts are sourced directly from the official live webcast or the company’s official investor relations website. We use the exact words spoken during the call with no paraphrasing of the core discussion.
Full verbatim transcripts are typically published within 4–12 hours after the call ends. Same-day availability is guaranteed for all S&P 500 and most mid-cap companies.
No material content is ever changed or summarized in the “Full Transcript” section. We only correct obvious spoken typos (e.g., “um”, “ah”, repeated 10 times”, or clear misspoken ticker symbols) and add speaker names/titles for readability. Every substantive sentence remains 100% as spoken.
When audio quality is poor or multiple speakers talk over each other, we mark the section instead of guessing. This ensures complete accuracy rather than introducing potential errors.
They are generated by a specialized financial-language model trained exclusively on 15+ years of earnings transcripts. The model extracts financial figures, guidance, and tone with 97%+ accuracy and is regularly validated against human analysts. The full raw transcript always remains available for verification.
